Bird‑Flu Trials and Dairy Cases
- The UK has launched an H5N1 vaccine trial and Moderna began a Phase 3 mRNA trial targeting high‑risk groups. - Moderna’s trial focuses on people over 65 and poultry workers, while governments monitor mammal spillover including U.S. dairy cows. - Reports noted scattered human cases like Cambodia’s fourth H5N1 infection this year, keeping surveillance and vaccine work active. (bbc.co.uk) (memesita.com) (bnonews.com)
Bird flu vaccine testing moved into a larger human trial this week as Britain and Moderna started Phase 3 work on an H5 shot. (nihr.ac.uk) (newswire.com) Influenza vaccines train the immune system to recognize a virus before widespread illness starts. This candidate, called mRNA-1018, uses the same messenger RNA approach used in Covid-19 shots to teach the body to spot an H5 bird-flu strain. (nihr.ac.uk) (sciencemediacentre.org) The new Phase 3 study plans to enroll about 4,000 adults age 18 and older in the United Kingdom and United States, with roughly 75% recruited at UK sites. Moderna said first participants in both countries have already been dosed. (sciencemediacentre.org) (newswire.com) Researchers are asking for people at higher exposure risk, including poultry workers, and Moderna said the trial also focuses on adults 65 and older. The UK study is backed by the National Institute for Health and Care Research and run under a government partnership managed by the UK Health Security Agency. (independent.co.uk) (nihr.ac.uk) Governments are building these trials while H5 viruses keep moving beyond birds. The Centers for Disease Control and Prevention said H5 bird flu is still widespread in wild birds and has also caused outbreaks in U.S. poultry and dairy cows, with sporadic infections in dairy and poultry workers. (cdc.gov) The dairy-cow cases changed the picture in 2024 because they showed the virus circulating in a mammal population tied to farm workers and milk production. The Centers for Disease Control and Prevention said the Texas case confirmed on April 1, 2024 was the first known likely mammal-to-human transmission linked to infected dairy cattle. (cdc.gov) (fda.gov) U.S. officials still describe the current public-health risk as low, but they have kept surveillance systems running and dairy monitoring in place. California said on March 25, 2026 that quarantines had been lifted from its dairies, while statewide testing and monitoring would continue because the state still counts as affected. (cdc.gov) (cdfa.ca.gov) Human cases outside the United States have stayed scattered rather than sustained, which is why health agencies are watching for clusters and genetic changes instead of community spread. Cambodia reported a fourth human H5N1 case of 2026 on April 22, involving a 66-year-old woman in Svay Rieng province. (bnonews.com) (english.news.cn) The World Health Organization’s Western Pacific update for April 10 to 16 said no new H5N1 cases were reported in that week, and listed 993 human H5N1 cases and 477 deaths globally from 2003 to January 22, 2026. That fatality record is one reason vaccine makers and governments are trying to have a shot ready before wider human spread appears. (who.int) (cepi.net) The financing reflects that planning. In December 2025, the Coalition for Epidemic Preparedness Innovations said it would invest up to $54.3 million to help move Moderna’s H5 vaccine candidate toward licensure, with a pledge that 20% of pandemic manufacturing capacity would be set aside for low- and middle-income countries if the shot is licensed. (cepi.net) The next readout is straightforward: whether this larger trial shows the shot is safe and produces the immune response regulators want to see. Until then, the bird-flu story is still two tracks at once — vaccines moving through trials, and animal and human surveillance trying to catch the virus before it changes again. (nihr.ac.uk) (cdc.gov)
